CME Group announced that it will file a lawsuit against the U.S. Commodity Futures Trading Commission (CFTC) following the regulator’s approval of a perpetual futures product earlier this month.
Regulatory Dispute Over Perpetual Futures
Chief Executive Terrence Duffy argued that the CFTC’s endorsement of Kalshi’s perpetual futures does not satisfy the Dodd‑Frank Act’s definition of a swap, which requires two parties to exchange payments. He contended that, under the Act, the approved instruments function as swaps rather than futures, thereby subjecting them to a different regulatory framework.
CME’s Position and Market Outlook
Duffy, who plans to leave his role in 2027, said CME must first clarify the applicable rules before considering its own perpetual futures listings, noting that the current guidance remains ambiguous. He warned that investors and market participants could face compliance challenges if the swap classification is enforced without clear standards.
Criticism of CFTC Practices
When asked about potential misrepresentations by the CFTC, Duffy indicated that the agency’s recent communication on 24/7 trading described a non‑binding guideline as a formal rule, suggesting a broader pattern of inaccuracies. He concluded that numerous regulatory issues persist, which could affect the broader crypto and blockchain markets.